Skip to content
★ Sign in to follow
JP

Jonathan Peacock

Chairman
Arix Bioscience plc
Total declarations
5
Company
1
▲ Purchases (2 ops.)
€297k
▼ Sales (0 ops.)
—

Latest filing published 16 Mar 2020 for Arix Bioscience plc.

Filing timeline

BuySale
Jonathan Peacock

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jonathan Peacock: trading record in brief

Jonathan Peacock appears in our data through filings on Arix Bioscience plc shares, published by RNS (LSE). Over a trading history stretching from 26 May 2017 to 12 March 2020, the count stands at 5 filings.

On the market, this insider has only ever bought: 2 purchases, €297k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.

On 16 March 2020 came the latest disclosure, a share grant in Arix Bioscience plc. The most recent open-market purchase was published on 21 March 2018, 3,154 days ago. Filings reach the RNS (LSE) feed a median of 4 days after the trade. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Jonathan Peacock

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    ChairmanExecutivesArix Bioscience plc
    0FCA-NSM
    231,348 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_202003160300PR_NEWS_UKDISCLO_0012_20200331164957015_15666
  • ◆
    ChairmanExecutivesArix Bioscience plc
    0FCA-NSM
    298,507 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-2
  • ▲
    ChairmanExecutivesArix Bioscience plc
    202,500 GBP15FCA-NSM
    90,000 shares@ £2.2577.6% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20180321114002_13575710_20200330111427142_9794
    Canonical exit: 18 Jun 2018 (T+90)
  • ▲
    ChairmanExecutivesArix Bioscience plc
    57,741 GBP24FCA-NSM
    28,016 shares@ £2.06122.4% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20170605070004_13248596_20200330131521973_2859-2
    Canonical exit: 31 Aug 2017 (T+90)
  • ◆
    ChairmanExecutivesArix Bioscience plc
    0FCA-NSM
    379,746 sharesOutside of a trading venueISIN GB00BD045071FCA-NSM:LSE20170530070012_13241449_20200330131531495_22267-1

5 of 5 declarations